Editas Medicine

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). 

CEO
Gilmore O’Neill
CEOGilmore O’Neill
Employees
87
Employees87
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
87
Employees87

EDIT Key Statistics

Market cap
422.79M
Market cap422.79M
Price-Earnings ratio
-2.26
Price-Earnings ratio-2.26
Dividend yield
Dividend yield
Average volume
2.37M
Average volume2.37M
High today
High today
Low today
Low today
Open price
$2.72
Open price$2.72
Volume
125.27K
Volume125.27K
52 Week high
$4.54
52 Week high$4.54
52 Week low
$1.66
52 Week low$1.66

Stock Snapshot

With a market cap of 422.79M, Editas Medicine(EDIT) trades at $2.80. The stock has a price-to-earnings ratio of -2.26.

Editas Medicine(EDIT) stock opened on 2026-06-24 at $2.72. The price climbed to — and dipped to —.

The Editas Medicine(EDIT)'s current trading volume is 125.27K, compared to an average daily volume of 2.37M.

During the past year, Editas Medicine(EDIT) stock moved between $1.66 at its lowest and $4.54 at its peak.

During the past year, Editas Medicine(EDIT) stock moved between $1.66 at its lowest and $4.54 at its peak.

EDIT News

Investing.com 5d
Editas Medicine elects two directors and ratifies auditor at annual meeting - Investing.com

...

Editas Medicine elects two directors and ratifies auditor at annual meeting - Investing.com
TipRanks 6d
Editas Medicine Shareholders Back Board, Pay and Auditor

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Analyst ratings

58%

of 12 ratings
Buy
58.3%
Hold
25%
Sell
16.7%

People also own

Based on the portfolios of people who own EDIT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.